US M&A and equity raisings
3,392 deals since January 2025, with sources and adviser credits where available · as at 20 Nov 2026 · Venture rounds
Deals dated after 30 September 2026 are still being collected.
112 deals · US$144bndisclosed · Biotech · Clear
Columns
| Date | Target | Vendor | Acquirer | Type | Status | Value US$m | Sector | Advisers |
|---|---|---|---|---|---|---|---|---|
| 2026 | AttaiBeckley | – | Eli Lilly and Company | Acquisition | Announced | 3,800.0 | Biotech+2 | Moelis & Company (sell-side) |
| 2026 | FireFly Biologics | – | J&J | Acquisition | Announced | 1,000.0 | Biotech+1 | Centerview Partners (sell-side) |
| Dec 2025 | Dynavax Technologies | – | Sanofi | Acquisition | Announced | 2,200.0 | Biotech+1 | Centerview Partners (sell-side)Goldman Sachs (sell-side)Cooley (sell-side)Weil, Gotshal & Manges (buy-side) |
| Dec 2025 | Amicus Therapeutics | – | BioMarin | Acquisition | Announced | 4,800.0 | Biotech+2 | Centerview Partners (sell-side)Goldman Sachs (sell-side)Kirkland & Ellis (sell-side)Morgan Stanley (buy-side)Jones Day (buy-side) |
| Dec 2025 | Generation Bio Co. | – | XRA 7 Corp. | Acquisition | Announced | – | Biotech+1 | TD Securities (sell-side)WilmerHale (sell-side)Gibson Dunn (buy-side) |
| Dec 2025 | MindWave Innovations | – | Apimeds Pharmaceuticals US | Merger | Completed | – | Biotech+1 | Duane Morris (sell-side)Nelson Mullins Riley & Scarborough (buy-side) |
| Nov 2025 | Aptose Biosciences | – | HS North America | Acquisition | Announced | – | Biotech+2 | Locust Walk (sell-side)Stikeman Elliott (buy-side) |
| Oct 2025 | Avidity Biosciences | – | Novartis | Acquisition | Announced | 11,000.0 | Biotech+2 | Goldman Sachs (sell-side)Barclays (sell-side)Kirkland & Ellis (sell-side)Covington & Burling (buy-side)Freshfields (buy-side)Gordon Dyal & Co. (buy-side) |
| Oct 2025 | Astria Therapeutics | – | BioCryst Pharmaceuticals | Acquisition | Completed | 700.0 | Biotech+2 | Evercore (sell-side)Sidley Austin (sell-side)BofA Securities (buy-side)Covington & Burling (buy-side) |
| Jul 2025 | DiamiR Biosciences Corp. | – | Aptorum Group | Merger | Completed | – | Diagnostics+1 | H.C. Wainwright & Co. (sell-side) |
| Feb 2025 | Instinct Bio Technical Company | – | Relativity Acquisition Sponsor | Merger | Pending | 225.0 | Biotech | Hunter Taubman Fischer & Li (sell-side)Chardan (sell-side)Loeb & Loeb (buy-side)Ogier (buy-side) |
| – | Telomir Pharmaceuticals | – | – | Merger | Announced | 47.1 | Biotech+1 |
Deals come from SEC filings (merger proxies, tender offers, 8-K announcements and IPO prospectuses), the deal pages and transaction lists of law firms and banks, companies' press releases and the press. How the data is built